LIFT BIOSCIENCE

• 72110 - Research and experimental development on biotechnology

LIfT is the only Biotech company in the world with a Neutrophil Based Cell Therapy Platform, and we are interested in out-licensing and research deals in multiple therapy areas... LIfT Biosciences is preclinical UK & EU based Biotech developing an innate allogeneic first-in-class neutrophil based cell therapy platform called N-LIfT (Neutrophil based Leukocyte Infusion Therapy)... LIfT Biosciences is a pre-clinical stage biotech with The World's only Neutrophil based Cell Therapy Platform. The LIfT platform is allogeneic and can be used to produce different Immuno-Modulating Alpha Neutrophils (IMANs) for treating a range of different therapeutic indications, including solid tumours.

Also known as: LIfT, LifT Bioscience Ltd, LIfT Biosciences, LIFT BIOSCIENCES LIMITED, LIfT BioSciences Ltd.

Registration numbers: 09277638 (CH)

Primary location: London United Kingdom